Emily Bauer is currently the Vice President and Head of Global Commercialization Strategy at BioNTech SE, a position held since 2025. Previously, they accumulated extensive experience in oncology marketing and medical writing at prominent organizations, including Bristol Myers Squibb and Medicus International. Emily earned a BS in Biochemistry/Molecular Biology from the University of Wisconsin-Eau Claire and a PhD in Biochemistry/Structural Biology from Joan & Sanford I. Weill Medical College of Cornell University. Their career reflects a strong foundation in both scientific research and commercial strategy within the pharmaceutical industry.
This person is not in any teams
This person is not in any offices